OPTIMER PHARMACEUTICALS INC Stock-Based Compensation
OPTIMER PHARMACEUTICALS INC reported Stock-Based Compensation of $7.12 million for the 6-month period ending 2013-06-30, per its 10-Q filed 2013-08-07.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2013-08-07
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-06-30 was $2.80M, a 29.20% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2013-03-31 was $4.32M, a 39.10% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-12-31 was $2.58M, a 41.40% decline year-over-year.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, noncash expense for the quarter ending 2012-09-30 was $3.07M, a 13.91% increase year-over-year.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2012 was $12.71M, a 7.82% increase from fiscal 2011.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2011 was $11.79M, a 84.86% increase from fiscal 2010.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2010 was $6.38M, a 127.05% increase from fiscal 2009.
- OPTIMER PHARMACEUTICALS INC share-based payment arrangement, noncash expense for fiscal 2009 was $2.81M.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2013-06-30 | $2.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $7.12M 10-Q · filed 2013-08-07 | $9.70M derived: sum of 3 quarters · filed 2013-08-07 | $12.77M derived: sum of 4 quarters · filed 2013-08-07 |
| 2013-03-31 | $4.32M 10-Q · filed 2013-05-10 | $6.90M derived: sum of 2 quarters · filed 2013-05-10 | $9.97M derived: sum of 3 quarters · filed 2013-05-10 | $13.92M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $5.65M derived: sum of 2 quarters · filed 2013-03-18 | $9.60M derived: sum of 3 quarters · filed 2013-08-07 | $12.71M 10-K · filed 2013-03-18 |
| 2012-09-30 | $3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $7.02M derived: sum of 2 quarters · filed 2013-08-07 | $10.13M 10-Q · filed 2012-11-02 | $14.53M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-06-30 | $3.95M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $7.06M 10-Q · filed 2013-08-07 | $11.46M derived: sum of 3 quarters · filed 2013-08-07 | $14.16M derived: sum of 4 quarters · filed 2013-08-07 |
| 2012-03-31 | $3.11M 10-Q · filed 2013-05-10 | $7.51M derived: sum of 2 quarters · filed 2013-05-10 | $10.20M derived: sum of 3 quarters · filed 2013-05-10 | $12.71M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $7.10M derived: sum of 2 quarters · filed 2013-03-18 | $9.61M derived: sum of 3 quarters · filed 2013-03-18 | $11.79M 10-K · filed 2013-03-18 |
| 2011-09-30 | $2.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $5.20M derived: sum of 2 quarters · filed 2012-11-02 | $7.38M 10-Q · filed 2012-11-02 | $9.53M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-06-30 | $2.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | $4.69M 10-Q · filed 2012-08-03 | $6.83M derived: sum of 3 quarters · filed 2013-03-18 | $7.91M derived: sum of 4 quarters · filed 2013-03-18 |
| 2011-03-31 | $2.18M 10-Q · filed 2012-05-10 | $4.32M derived: sum of 2 quarters · filed 2013-03-18 | $5.40M derived: sum of 3 quarters · filed 2013-03-18 | |
| 2010-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $3.22M derived: sum of 2 quarters · filed 2013-03-18 | $6.38M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $4.23M 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | $3.15M 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $2.81M 10-K · filed 2012-03-08 |